Skip to content
Search

Latest Stories

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce

The UK government has announced plans to update legislation to enable more services and individuals to provide take-home supplies of naloxone – a life-saving opioid overdose antidote - over the next few weeks.

Naloxone can immediately reverse the effects of an opioid overdose by reversing breathing difficulties. The medicine can be administered by anyone in an emergency. However, current legislation allows only drug and alcohol treatment services to supply it without a prescription to individuals for future use.


The Department of Health and Social Care (DHSC) confirmed on Tuesday (14 May) that more professionals, including nurses, paramedics, police officers, probation officers and pharmacy professionals, will be able to supply the medicine without a prescription to save lives.

Health and Social Care Secretary Victoria Atkins warned that opioid addiction can ruin lives and it accounts for the largest proportion of drug-related deaths across the UK.

“We are working hard to reduce those numbers by expanding access to naloxone to save the lives of the most vulnerable,” she said.

The UK government is aiming to prevent nearly 1,000 drug-related deaths in England by the end of 2025.

The decision to widen access to take-home naloxone follows two government consultations conducted in 2021 and 2024, respectively.

“As a result of the overwhelming support, we are proceeding with the proposed legislative changes during spring 2024,” the government said in its response to the latest consultation, also published on Tuesday.

Additionally, the government has released a new 10-year strategic plan to expand and improve the drug and alcohol treatment and recovery workforce.

Key milestones outlined included recruiting more new and experienced professionals into the sector and developing better training for roles that are presently unregulated, such as drug and alcohol workers.

Developed by the Office for Health Improvement and Disparities (OHID) and NHS England, the new workforce plan builds on the progress of the government’s previous 10-year strategy to combat illicit drug use and reduce drug deaths.

As part of the strategy, an additional £532 million is being invested between 2022 and 2025 to improve the capacity and quality of drug and alcohol treatment. More than 3,900 additional staff have been recruited thus far through this funding.

The Health Secretary noted that the 10-year workforce plan will expand and boost the training of the next generation of drug and alcohol workers to improve services and support people to get their lives back on track.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less